trending Market Intelligence /marketintelligence/en/news-insights/trending/cbhqdwUP5s5_qGTSmItl1A2 content
Log in to other products

Login to Market Intelligence Platform


Looking for more?

Contact Us

Request a Demo

You're one step closer to unlocking our suite of comprehensive and robust tools.

Fill out the form so we can connect you to the right person.

If your company has a current subscription with S&P Global Market Intelligence, you can register as a new user for access to the platform(s) covered by your license at Market Intelligence platform or S&P Capital IQ.

  • First Name*
  • Last Name*
  • Business Email *
  • Phone *
  • Company Name *
  • City *
  • We generated a verification code for you

  • Enter verification Code here*

* Required

Thank you for your interest in S&P Global Market Intelligence! We noticed you've identified yourself as a student. Through existing partnerships with academic institutions around the globe, it's likely you already have access to our resources. Please contact your professors, library, or administrative staff to receive your student login.

At this time we are unable to offer free trials or product demonstrations directly to students. If you discover that our solutions are not available to you, we encourage you to advocate at your university for a best-in-class learning experience that will help you long after you've completed your degree. We apologize for any inconvenience this may cause.

In This List

Schrödinger plans $100M IPO on Nasdaq

COVID-19 Pandemic Likely To Cause US Telemedicine Boom

Gauging Supply Chain Risk In Volatile Times

S&P Global Market Intelligence

Cannabis: Hashing Out a Budding Industry


IFRS 9 Impairment How It Impacts Your Corporation And How We Can Help

Schrödinger plans $100M IPO on Nasdaq

Schrödinger LLC is planning an IPO of up to $100 million of its common stock on the Nasdaq Global Market.

The New York-based company provides software solutions for life sciences and material research. It has applied to list its shares on the exchange under the symbol SDGR.

The company plans to use the proceeds to advance its computational platform and drug discovery programs. Funds will also be used for general corporate purposes, including working capital, operating and capital expenditures.

Ramy Farid is president and CEO of Schrödinger.

The Bill & Melinda Gates Foundation Trust and David Shaw, along with affiliated entities, own a 5% stake in the company.

Schrödinger raised a total of $110 million from existing and new investors to fund its computational platform and the expansion of its therapeutic pipeline in May 2019.

Morgan Stanley & Co. LLC, BofA Securities LLC, Jefferies LLC and BMO Capital Markets Corp. are underwriters for the IPO.